Increased Levels of Interleukin‐10 and IgG3 Are Hallmarks of Indian Post–Kala-Azar Dermal Leishmaniasis-Reference-Cited by-同舟云学术

Increased Levels of Interleukin‐10 and IgG3 Are Hallmarks of Indian Post–Kala-Azar Dermal Leishmaniasis

Published:2008-06-15 Issue:12 Volume:197 Page:1762-1771
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Ganguly Sudipto,Das Nilay Kanti,Panja Moumita,Pal Shekhar,Modak Dolanchampa,Rahaman Mehebubar,Mallik Sudeshna,Guha Subhashis Kamal,Pramanik Netai,Goswami Ramapada,Barbhuiya Joyashree Nath,Saha Bibhuti,Chatterjee Mitali

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/197/12/1762/18051690/197-12-1762.pdf

Reference42 articles.

1. Advances in leishmaniasis

2. Leishmaniasis: current situation and new perspectives

3. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis

4. Short communication: Post-kala-azar dermal leishmaniasis - an appraisal

5. Post-kala-azar dermal leishmaniasis

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;PLOS Neglected Tropical Diseases;2024-04-16

2. Status of B‐Lymphocyte Subsets and Their Homing Markers in Patients With Post‐Kala‐Azar Dermal Leishmaniasis;Parasite Immunology;2024-03

3. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;2023-09-07

4. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination;Frontiers in Immunology;2023-08-11

5. Leishmania donovani induces CD300a expression to dampen effector properties of CD11c+ dendritic and antigen activated CD8+ T cells;Acta Tropica;2023-03